Curated insights • How it Works • Practical Pearls • Evidence Base
| Age ≥ 75 ( −2 ), 65-74 ( −1 ), <65 ( 0 ) |
| Cigarette Smoking |
| Diabetes Mellitus |
| MI at Presentation |
| Prior MI or PCI |
| Stent Diameter < 3mm |
| Paclitaxel-eluting Stent |
| Congestive Heart Failure / LVEF < 30% |
| Vein Graft Stent |
| Score < 2 |
| Score ≥ 2 |
The DAPT score is a "trade-off" tool. A high score suggests that the risk of stent thrombosis or recurrent MI is high enough to justify the increased bleeding risk of prolonged dual antiplatelet therapy.
Development and Validation of a Prediction Rule to Guide the Duration of Dual Antiplatelet Therapy.
Curated insights • How it Works • Practical Pearls • Evidence Base
| Age ≥ 75 ( −2 ), 65-74 ( −1 ), <65 ( 0 ) |
| Cigarette Smoking |
| Diabetes Mellitus |
| MI at Presentation |
| Prior MI or PCI |
| Stent Diameter < 3mm |
| Paclitaxel-eluting Stent |
| Congestive Heart Failure / LVEF < 30% |
| Vein Graft Stent |
| Score < 2 |
| Score ≥ 2 |
The DAPT score is a "trade-off" tool. A high score suggests that the risk of stent thrombosis or recurrent MI is high enough to justify the increased bleeding risk of prolonged dual antiplatelet therapy.
Development and Validation of a Prediction Rule to Guide the Duration of Dual Antiplatelet Therapy.